Safety and Efficacy of a 90-day Vaginal Matrix Ring Containing Dapivirine and a Contraceptive in the Prevention of HIV-1 Infection in Women.
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2014
At a glance
- Drugs Dapivirine (Primary) ; Contraceptives
- Indications HIV-1 infections; Pregnancy
- Focus Therapeutic Use
- 04 Jun 2014 New trial record
- 08 May 2014 This trial will start in 2015, according to Janssen Media release.